Federated Health Intelligence Network
The human layer beneath the validation engine.
FHIN is the verified signal network beneath AimwellBio’s adversarial validation layer: credentialed contributors who submit, review and score signal data, so AI-generated science is challenged by experts before it reaches a decision.
Three ways in
Observer, contributor, institution.
Observer
Read access to the AimwellBio intelligence layer, for credentialed healthcare professionals who want to stay current on AI-generated biopharma science without committing to contribute. No submission required.
Apply for Observer accessFHIN Contributor
Active participation in the signal verification layer: you submit datasets, review claims or score intelligence outputs. Contributions earn credits redeemable for premium access and a citation-eligible member badge. Requires credential review.
Apply as a contributorInstitutional
Pharmaceutical companies and healthcare systems that want full network access and direct data integration. The verified contributor total is available to qualified institutional partners under NDA.
Request accessWhat FHIN is
Clear about what it is, and what it is not.
FHIN is
- A verified network of credentialed contributors who submit, review and score signal data
- The human layer beneath the adversarial validation engine: expert review at scale
- A structured way to earn credit for the intelligence work you are already doing
- Open to healthcare professionals, researchers and regulatory experts who meet eligibility criteria
FHIN is not
- A data marketplace: you retain rights to your intellectual property
- Open to the general public without credential verification
- A publishing platform: contributions are used for validation, not public attribution
- A replacement for peer review: FHIN signals inform the validation layer, not journal submission
Every FHIN signal traces to a primary public-source institution: FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, USPTO or EMA. AimwellBio does not generate or infer signals; it indexes, deduplicates and confidence-scores from authoritative registries.
Three questions every healthcare leader is asking
Questions FHIN exists to answer
Who qualifies to contribute
Credentialed experts in three areas.
Clinical & research
MD, DO, PhD, PharmD or equivalent with active institutional affiliation or verifiable research history.
Regulatory & medical affairs
Experience in FDA, EMA or equivalent regulatory submissions, or an active medical affairs role at a biopharma organization.
Health economics & outcomes
HEOR specialists, health economists or outcomes researchers with published work or institutional record.
Not sure if you qualify? Start with Observer access, free for all credentialed professionals. Contributor eligibility is reviewed after application. Apply as Observer
How the network works
Four steps from registration to credit.
- 01
Register
Create your contributor profile and select your tier based on contribution capacity.
- 02
Submit data
Submit datasets with full metadata, methodology documentation and regulatory compliance details.
- 03
Quality scoring
Automated and human review assigns quality metrics. Feedback is provided for improvements.
- 04
Earn credits
Approved datasets generate credits based on usage and quality, redeemable for platform access.
Participation levels
- ReaderAccess to approved datasets, for researchers and analysts getting started.
- SubmitterSubmit and earn, for active researchers and small institutional teams.
- ValidatorHeavy contributors, for institutions running clinical trials and research programs.
- Network AnchorFull network access, for pharmaceutical companies and healthcare systems.
Credit amounts and any service discounts are set out when you apply.
Founding cohort · applications open
The first contributors set the verification norms.
The first approved contributors shape the credentialing standards and receive founding-tier benefits that lock in at enrollment. This is not a waitlist. If a verification layer for healthcare intelligence is going to exist, would you rather help define its standard or subscribe to it later?
- Applications are open, reviewed within 48 hours
- Credential verification required: healthcare professionals, researchers, regulatory experts
- Founding contributor benefits are locked in at enrollment and not available to later cohorts
- Network size is not publicly disclosed. We do not inflate counts.
Frequently asked
FHIN and AimwellBio, in plain words.
Who is AimwellBio built for?
AimwellBio is built for the people who sign their name to a decision: biopharma and enterprise biotech teams, individual practitioners, investors and capital allocators, and sovereign health ministries. Credentialed professionals can access the Observer tier at no cost. Institutional access runs through the platform tiers.
What evidence does AimwellBio use?
AimwellBio draws on regulatory filings, clinical and scientific literature, market and competitive signals, and the contributor network behind FHIN. Outputs are traced to their sources rather than asserted, and the evidence hierarchy and confidence scoring that govern how sources are weighted are documented in the published Standard.
What is FHIN?
FHIN is the Federated Health Intelligence Network, the contributor and verification layer behind the platform. Credentialed professionals participate in it, and their verified participation is what distinguishes a federated network from an unsourced aggregate. A founding contributor cohort is open.
How can an organization work with AimwellBio?
Credentialed professionals can start on the Observer tier at no cost. Organizations requiring institutional scope can review the access tiers or request access directly, and deployment runs through a five-step process: assess, configure, ingest, activate, and scheduled refresh.
Questions? corporate@aimwellbio.com